Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit
Xin-Ming Shen, … , Steven M. Sine, Andrew G. Engel
Xin-Ming Shen, … , Steven M. Sine, Andrew G. Engel
Published January 25, 2018
Citation Information: JCI Insight. 2018;3(2):e97826. https://doi.org/10.1172/jci.insight.97826.
View: Text | PDF
Research Article Muscle biology Neuroscience

Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit

  • Text
  • PDF
Abstract

We identify 2 homozygous mutations in the ε-subunit of the muscle acetylcholine receptor (AChR) in 3 patients with severe congenital myasthenia: εR218W in the pre-M1 region in 2 patients and εE184K in the β8-β9 linker in 1 patient. Arg218 is conserved in all eukaryotic members of the Cys-loop receptor superfamily, while Glu184 is conserved in the α-, δ-, and ε-subunits of AChRs from all species. εR218W reduces channel gating efficiency 338-fold and AChR expression on the cell surface 5-fold, whereas εE184K reduces channel gating efficiency 11-fold but does not alter AChR cell surface expression. Determinations of the effective channel gating rate constants, combined with mutant cycle analyses, demonstrate strong energetic coupling between εR218 and εE184, and between εR218 and εE45 from the β1-β2 linker, as also observed for equivalent residues in the principal coupling pathway of the α-subunit. Thus, efficient and rapid gating of the AChR channel is achieved not only by coupling between conserved residues within the principal coupling pathway of the α-subunit, but also between corresponding residues in the ε-subunit.

Authors

Xin-Ming Shen, Joan M. Brengman, Shelley Shen, Hacer Durmus, Veeramani Preethish-Kumar, Nur Yuceyar, Seena Vengalil, Atchayaram Nalini, Feza Deymeer, Steven M. Sine, Andrew G. Engel

×

Figure 3

Mutant cycle analysis.

Options: View larger image (or click on image) Download as PowerPoint
Mutant cycle analysis.
(A) A mutant cycle of energetic interaction among...
(A) A mutant cycle of energetic interaction among εE184 and εR218 and among εE45 and εR218. Single-channel currents correspond to each species of acetylcholine receptor (AChR) elicited by 300 μM acetylcholine (ACh). Numbers over the arrows indicate the difference in the apparent gating free energy between 2 different AChRs in kcal/mol. The standard error (SE) values were computed as described under Methods. The 95% confidence limit, or twice the SE, indicates a coupling energy significantly different from zero. The indicated diagonal arrows show the coupling free energy (ΔΔGint) for εE184R/εR218E and εE45R/εR218E. (B) A mutant cycle of energetic interaction among εD138 and εR218. (C) Stereo view of the interface between extracellular domains and transmembrane domains shows spatial disposition of interactions of Arg218 in pre-M1 with Glu184 in the β8-9 loop revealed by mutant cycle analysis in the current work, with Glu45 in the β1-2 loop and with Asp138 in the Cys-loop proposed in the Discussion.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts